Compare Medtronic PLC (MDT) vs Realty Income Corp (O) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Realty Income (O) trades at $65.04, down 1.02% today, near the analyst consensus price target of $67.50. The stock shows a bullish technical setup with strong moving average signals, though RSI levels suggest mild overbought conditions. Recent earnings have missed expectations for three consecutive quarters, but revenue growth remains steady, rising to $5.75B in 2025. The company maintains a high dividend yield with consistent payouts, supported by robust operating cash flow of $4.0B.

Outlook is cautiously optimistic with a solid dividend profile and expansion through partnerships, but elevated P/E of 53.86 and recent earnings misses pose valuation and execution risks. Debt levels have increased, with debt-to-asset ratio reaching 39.93% in 2025, adding financial leverage concerns. Analyst sentiment is mixed with 41% buy ratings, reflecting balanced views on growth potential versus rich valuations.